EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetics of Celiac Disease in Southern Brazil: High‐Resolution HLA Haplotypes and Non‐ HLA Polymorphisms

Fernanda Vitório da Silva iD, Valéria Bumiller-Bini Hoch iD, Eduardo Delabio Auer iD, Priscila Ianzen Dos Santos iD, Noah Cline iD, Luana Caroline Oliveira, Jennifer Elisabeth Hundt, Michael Wittig iD, Andre Franke, Paul J Norman iD, Angelica Beate Winter Boldt iD

HLA · 2026

DOI: 10.1111/tan.70972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2026. Verfasst von Fernanda Vitório da Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Molecular Genetics (LGMH), Department of Genetics, Federal University of Paraná (UFPR), Centro Politécnico, Jardim das Américas, …. Hauptthemen laut MEDLINE: Celiac Disease, Haplotypes, HLA-DQ alpha-Chains, Genetic Predisposition to Disease. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celiac disease (CeD) is an autoimmune enteropathy triggered by gluten ingestion in genetically predisposed individuals, who frequently present HLA‐DQ2 or HLA‐DQ8 haplotypes. To examine the genetic architecture of CeD in the admixed South Brazilian population, we sequenced the HLA alleles to high resolution and genotyped 16 non‐HLA polymorphisms, previously identified through genome‐wide association studies of Europeans in 171 CeD diagnosed patients and 195 controls. Controls had no CeD diagnosis, no first‐degree affected relatives, and were negative for anti‐TTg autoantibodies. As expected, we observed a predominance of HLA ‐ DQA1*05:01:01~DQB1*02:01:01 (DQ2.5) and HLA ‐ DQA1*02:01:01~DQB1*02:02:01 (DQ2.2) haplotypes among patients (51.7% and 40.2%, respectively). The ancestral 8.1 haplotype of HLA Class I and II alleles presented the highest odds of developing CeD (OR = 6.54, pcorr = 0.000065). By contrast, HLA ‐ DQA1*01:02:01 , HLA ‐ DQB1*05:01:01 , HLA ‐ DRB1*08:02:01 and HLA ‐ DRB1*13:01:01 were more frequent among controls (OR < 0.4, pcorr < 0.01). In contrast to results obtained in populations of predominantly European origin, HLA‐DQ8 frequencies did not differ between patients and controls. Among non‐HLA loci, rs6691768*G (g.61326191G > A) in NFIA was associated with protection (OR = 0.32, pcorr = 0.039) and rs653178*C ( g.111569952C > T ) (OR = 1.49, pcorr = 0.042) in ATXN2 was associated with susceptibility. This is the first high‐resolution HLA genotyping study of CeD in Brazil, providing a comprehensive overview of genetic susceptibility in an admixed population and highlighting new potential modulatory variants beyond the classical HLA loci.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseHaplotypesHLA-DQ alpha-ChainsGenetic Predisposition to DiseaseHLA-DQ beta-ChainsPolymorphism, GeneticHLA-DRB1 ChainsHumansBrazilFemaleMaleAllelesGene FrequencyAdultCase-Control StudiesAdolescentMiddle AgedHLA-DQ AntigensChild

Stichwörter der Autor:innen

Brazilian populationHLA genotypingceliac diseasegenetic susceptibility

Substanzen

HLA-DQ alpha-ChainsHLA-DQA1 antigenHLA-DQ8 antigenHLA-DQ2 antigenHLA-DQ beta-ChainsHLA-DQB1 antigenHLA-DRB1 ChainsHLA-DQ Antigens

Autor:innen und Institutionen

  • Laboratory of Human Molecular Genetics (LGMH), Department of Genetics, Federal University of Paraná (UFPR), Centro Politécnico, Jardim das Américas, Curitiba, Paraná, Brazil.
  • Postgraduation Program in Genetics, Federal University of Paraná (UFPR), Centro Politécnico, Jardim das Américas, Curitiba, Paraná, Brazil.
  • Postgraduation Program in Internal Medicine, Federal University of Paraná (UFPR), Centro de Ciências da Saúde, Curitiba, Paraná, Brazil.
  • Department of Biomedical Informatics, University of Colorado, Austin, Colorado, USA.
  • Luebeck Institute of Experimental Dermatology, University of Luebeck, Luebeck, Germany.
  • Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University of Kiel, Kiel, Germany.

ORCID-Profile: Fernanda Vitório da Silva, Valéria Bumiller-Bini Hoch, Eduardo Delabio Auer, Priscila Ianzen Dos Santos, Noah Cline, Michael Wittig, Paul J Norman, Angelica Beate Winter Boldt

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • NIAID NIH HHS
  • NIH HHS
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, PROAP-01, Finance Code 001
  • Fundação Araucária
  • National Institutes of Health
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

da Silva, F. V., Hoch, V. B., Auer, E. D., Dos Santos, P. I., Cline, N., Oliveira, L. C., Hundt, J. E., Wittig, M., Franke, A., Norman, P. J., & Boldt, A. B. W. (2026). Genetics of Celiac Disease in Southern Brazil: High‐Resolution HLA Haplotypes and Non‐ HLA Polymorphisms. HLA. https://doi.org/10.1111/tan.70972

Vancouver

da Silva FV, Hoch VB, Auer ED, Dos Santos PI, Cline N, Oliveira LC, et al. Genetics of Celiac Disease in Southern Brazil: High‐Resolution HLA Haplotypes and Non‐ HLA Polymorphisms. HLA. 2026. doi:10.1111/tan.70972

BibTeX
@article{daSilva2026,
  author = {da Silva, Fernanda Vitório and Hoch, Valéria Bumiller-Bini and Auer, Eduardo Delabio and Dos Santos, Priscila Ianzen and Cline, Noah and Oliveira, Luana Caroline and Hundt, Jennifer Elisabeth and Wittig, Michael and Franke, Andre and Norman, Paul J and Boldt, Angelica Beate Winter},
  title = {Genetics of Celiac Disease in Southern Brazil: High‐Resolution HLA Haplotypes and Non‐ HLA Polymorphisms},
  journal = {HLA},
  year = {2026},
  doi = {10.1111/tan.70972}
}
Kostenlos starten →